HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection

Abstract : The COVID-19 pandemic has spread worldwide, yet the role of antiviral T cell immunity during infection and the contribution of immune checkpoints remain unclear. By prospectively following a cohort of 292 patients with melanoma, half of which treated with immune checkpoint inhibitors (ICIs), we identified 15 patients with acute or convalescent COVID-19 and investigated their transcriptomic, proteomic, and cellular profiles. We found that ICI treatment was not associated with severe COVID-19 and did not alter the induction of inflammatory and type I interferon responses. In-depth phenotyping demonstrated expansion of CD8 effector memory T cells, enhanced T cell activation, and impaired plasmablast induction in ICI-treated COVID-19 patients. The evaluation of specific adaptive immunity in convalescent patients showed higher spike (S), nucleoprotein (N), and membrane (M) antigen-specific T cell responses and similar induction of spike-specific antibody responses. Our findings provide evidence that ICI during COVID-19 enhanced T cell immunity without exacerbating inflammation.
Document type :
Journal articles
Complete list of metadata

https://hal-pasteur.archives-ouvertes.fr/pasteur-03334080
Contributor : Marie-Christine Vougny Connect in order to contact the contributor
Submitted on : Friday, September 3, 2021 - 2:26:50 PM
Last modification on : Thursday, May 12, 2022 - 9:04:07 AM
Long-term archiving on: : Saturday, December 4, 2021 - 7:19:42 PM

File

sciadv.abg4081.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Nader Yatim, Jeremy Boussier, Pauline Tetu, Nikaïa Smith, Timothée Bruel, et al.. Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection. Science Advances , American Association for the Advancement of Science (AAAS), 2021, 7 (34), pp.eabg4081. ⟨10.1126/sciadv.abg4081⟩. ⟨pasteur-03334080⟩

Share

Metrics

Record views

203

Files downloads

43